This site is intended for healthcare professionals
Cardiovascular Metabolism Learning Zone
Declaration of sponsorship Novartis Pharma AG

Type 2 Diabetes

Declaration of sponsorship Novartis Pharma AG
Read time: 175 mins
Last updated:21st Sep 2021
Published:10th Jun 2021

The prevalence of type 2 diabetes is growing at an alarming rate, however effective treatment options are available to reduce the risk and burden of complications.

  • Explore key learnings from the landmark VERIFY study in detail
  • Watch experts discuss type 2 diabetes considerations in specific populations
  • Learn more about gender differences in type 2 diabetes

Why are we not using this fantastic drug called communication more often?

 

Dr Auus Alzaid emphasises the need for progressive training and clinician responsibility to ensure that the power of communication is used to maximum advantage.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Disease progression: β-cell function and insulin sensitivity

 

Is disease progression in type 2 diabetes (T2DM) predictable? Regardless of intervention, data show that progressive loss of β-cell function and insulin sensitivity is a reality.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Key considerations in the management of T2DM in women

 

Professor Blüher discusses the critical phases through which women with type 2 diabetes mellitus (T2DM) must be guided.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Clinical inertia and treatment intensification

We explore the challenge of clinical inertia and the benefit of treatment intensification.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

How appropriate is it to refer to the patient as ‘failing’? Professor Del Prato considers a more positive, proactive approach to achieving and maintaining glycaemic control.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Clinically relevant gender differences and impact on risk

 

Professor Blüher highlights the impact of gender on both the development of type 2 diabetes mellitus (T2DM) and clinical outcomes. Can risk be identified and diminished?

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: